Review

• Regulatory aspects on repurposing of drugs in the management of COVID-19

  Priyansha Bhatia, Akash Chauhan, Gagan Porwal, Vikesh Shukla

  Pages 1-13

  • View PDF Abstract Download PDF DOI 10.22270/ijdra.v10i1.503
• Overview of Vaccine Regulations in European Union and Japan

  Dinesh Ingle, Raj Bhavsar, Jagruti Pawar, Atul Patil, Pankaj Nerkar

  Pages 14-22

  • View PDF Abstract Download PDF DOI 10.22270/ijdra.v10i1.505
• Audit requirements and expectations, The good and better about MDSAP Regulations

  Vidya Sagar, Deepak Patel, Piyush Patel, Anil Kumar, Avni Rana, Bhavin Trivedi, Vipul Bavisa

  Pages 23-27

  • View PDF Abstract Download PDF DOI 10.22270/ijdra.v10i1.506
• Comprehensive review and enhancing approaches for Pediatric investigation plan in USA, EU and India

  Radhika A. Shah, Kalpana G. Patel, Purvi Shah

  Pages 28-34

  • View PDF Abstract Download PDF DOI 10.22270/ijdra.v10i1.507
• Comparative overview of enhancing Drug pricing transparency in India and USA

  Radhika A. Shah, Kalpana G. Patel, Purvi Shah

  Pages 35-39

  • View PDF Abstract Download PDF DOI 10.22270/ijdra.v10i1.508
• Comparative overview of Registration and Approval process for Generic Drugs in BRICS Countries

  Dhanashree R. Deore, Pinkal H. Patel

  Pages 40-50

  • View PDF Abstract Download PDF DOI 10.22270/ijdra.v10i1.509
• Comparative study of Regulatory requirements of Drug Product in Emerging market

  Jitendra Kumar Badjatya, Anil Jangid, Prakash Dodiya, Saurabh Soni, Akshita Parekh, Deval Patel, Jaimin Patel

  Pages 51-82

  • View PDF Abstract Download PDF DOI 10.22270/ijdra.v10i1.510
• A Comparative Study of Medical Device Regulation in US and India

  Deepika Sagar, Priyanka Gupta

  Pages 83-87

  • View PDF Abstract Download PDF DOI 10.22270/ijdra.v10i1.511